Epigenetic Reprogramming in Host-Parasite Coevolution: The Toxoplasma Paradigm
- PMID: 35587934
- DOI: 10.1146/annurev-micro-041320-011520
Epigenetic Reprogramming in Host-Parasite Coevolution: The Toxoplasma Paradigm
Abstract
Like many intracellular pathogens, the protozoan parasite Toxoplasma gondii has evolved sophisticated mechanisms to promote its transmission and persistence in a variety of hosts by injecting effector proteins that manipulate many processes in the cells it invades. Specifically, the parasite diverts host epigenetic modulators and modifiers from their native functions to rewire host gene expression to counteract the innate immune response and to limit its strength. The arms race between the parasite and its hosts has led to accelerated adaptive evolution of effector proteins and the unconventional secretion routes they use. This review provides an up-to-date overview of how T. gondii effectors, through the evolution of intrinsically disordered domains, the formation of supramolecular complexes, and the use of molecular mimicry, target host transcription factors that act as coordinating nodes, as well as chromatin-modifying enzymes, to control the fate of infected cells and ultimately the outcome of infection.
Keywords: Toxoplasma gondii; epigenetics; innate immunity; secreted effectors; transcription.
Similar articles
-
The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.mBio. 2016 May 10;7(3):e00193-16. doi: 10.1128/mBio.00193-16. mBio. 2016. PMID: 27165797 Free PMC article.
-
The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-κB signalling via EZH2.Nat Microbiol. 2019 Jul;4(7):1208-1220. doi: 10.1038/s41564-019-0431-8. Epub 2019 Apr 29. Nat Microbiol. 2019. PMID: 31036909 Free PMC article.
-
Epigenetic Modifiers Alter Host Cell Transcription to Promote Toxoplasma Infection.ACS Infect Dis. 2022 Mar 11;8(3):411-413. doi: 10.1021/acsinfecdis.2c00054. Epub 2022 Feb 24. ACS Infect Dis. 2022. PMID: 35201740
-
Modulation of innate immunity by Toxoplasma gondii virulence effectors.Nat Rev Microbiol. 2012 Nov;10(11):766-78. doi: 10.1038/nrmicro2858. Nat Rev Microbiol. 2012. PMID: 23070557 Free PMC article. Review.
-
Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii.Front Cell Infect Microbiol. 2019 Apr 16;9:103. doi: 10.3389/fcimb.2019.00103. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31041194 Free PMC article. Review.
Cited by
-
The role of SIRT1 in the process of Toxoplasma gondii infection of RAW 264.7 macrophages.Front Microbiol. 2022 Nov 17;13:1017696. doi: 10.3389/fmicb.2022.1017696. eCollection 2022. Front Microbiol. 2022. PMID: 36466662 Free PMC article.
-
Toxoplasma protein export and effector function.Nat Microbiol. 2024 Jan;9(1):17-28. doi: 10.1038/s41564-023-01563-z. Epub 2024 Jan 3. Nat Microbiol. 2024. PMID: 38172621 Review.
-
Microsporidian EnP1 alters host cell H2B monoubiquitination and prevents ferroptosis facilitating microsporidia survival.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2400657121. doi: 10.1073/pnas.2400657121. Epub 2024 Aug 14. Proc Natl Acad Sci U S A. 2024. PMID: 39141344 Free PMC article.
-
In vitro production of cat-restricted Toxoplasma pre-sexual stages.Nature. 2024 Jan;625(7994):366-376. doi: 10.1038/s41586-023-06821-y. Epub 2023 Dec 13. Nature. 2024. PMID: 38093015 Free PMC article.
-
A Combination of Four Nuclear Targeted Effectors Protects Toxoplasma Against Interferon Gamma Driven Human Host Cell Death During Acute Infection.bioRxiv [Preprint]. 2023 Dec 25:2023.12.24.573224. doi: 10.1101/2023.12.24.573224. bioRxiv. 2023. Update in: mBio. 2024 Oct 16;15(10):e0212424. doi: 10.1128/mbio.02124-24. PMID: 38234811 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources